2seventy bio Inc (TSVT)
5.005
+0.14
(+2.77%)
USD |
NASDAQ |
May 16, 16:00
5.005
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Price to Book Value: 1.240 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 1.207 |
| May 14, 2024 | 1.172 |
| May 13, 2024 | 1.113 |
| May 10, 2024 | 1.085 |
| May 09, 2024 | 1.099 |
| May 08, 2024 | 1.110 |
| May 07, 2024 | 1.229 |
| May 06, 2024 | 1.227 |
| May 03, 2024 | 1.180 |
| May 02, 2024 | 1.222 |
| May 01, 2024 | 1.140 |
| April 30, 2024 | 1.13 |
| April 29, 2024 | 1.137 |
| April 26, 2024 | 1.054 |
| April 25, 2024 | 1.063 |
| April 24, 2024 | 1.058 |
| April 23, 2024 | 1.147 |
| April 22, 2024 | 1.152 |
| April 19, 2024 | 1.120 |
| April 18, 2024 | 1.150 |
| April 17, 2024 | 1.254 |
| April 16, 2024 | 1.204 |
| April 15, 2024 | 1.235 |
| April 12, 2024 | 1.249 |
| April 11, 2024 | 1.368 |
| Date | Value |
|---|---|
| April 10, 2024 | 1.296 |
| April 09, 2024 | 1.395 |
| April 08, 2024 | 1.365 |
| April 05, 2024 | 1.219 |
| April 04, 2024 | 1.242 |
| April 03, 2024 | 1.234 |
| April 02, 2024 | 1.224 |
| April 01, 2024 | 1.435 |
| March 31, 2024 | |
| March 28, 2024 | 1.075 |
| March 27, 2024 | 1.081 |
| March 26, 2024 | 0.9969 |
| March 25, 2024 | 0.9848 |
| March 22, 2024 | 1.031 |
| March 21, 2024 | 1.003 |
| March 20, 2024 | 0.9125 |
| March 19, 2024 | 0.9024 |
| March 18, 2024 | 0.8421 |
| March 15, 2024 | 0.8059 |
| March 14, 2024 | 0.7959 |
| March 13, 2024 | 0.8059 |
| March 12, 2024 | 0.9507 |
| March 11, 2024 | 0.9205 |
| March 08, 2024 | 0.9486 |
| March 07, 2024 | 1.081 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2594
Minimum
Nov 21 2023
1.994
Maximum
Nov 10 2022
1.194
Average
1.227
Median
Jan 19 2023
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 5.424 |
| Johnson & Johnson | 5.305 |
| Macrogenics Inc | 3.021 |
| Akebia Therapeutics Inc | -- |
| Tango Therapeutics Inc | 3.147 |
Price to Book Value Related Metrics
| PS Ratio | 3.613 |
| Price | 5.005 |
| Earnings Yield | -86.91% |
| Market Cap | 257.28M |